<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-antibiotics-09-00641">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dos Santos</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Seckler</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Ingle</surname>
    <given-names>A.P.</given-names>
   </name>
   <name>
    <surname>Gupta</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Galdiero</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Galdiero</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gade</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rai</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Silver Nanoparticles: Therapeutical Uses, Toxicity, and Safety Issues</article-title>
  <source>J. Pharm. Sci.</source>
  <year>2014</year>
  <volume>103</volume>
  <fpage>1931</fpage>
  <lpage>1944</lpage>
  <pub-id pub-id-type="doi">10.1002/jps.24001</pub-id>
  <?supplied-pmid 24824033?>
  <pub-id pub-id-type="pmid">24824033</pub-id>
 </element-citation>
</ref>
